Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

372.56 +6.71 (+1.83%)
Streaming Delayed Price Updated: 11:19 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left... 
Via Finterra
Topics Product Recall World Trade
News headline image
Stryker declares an $0.88 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker Corp (NYSE:SYK) Beats Q4 EPS Estimates, Provides 2026 Guidance ↗
Via Chartmill
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race
In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The... 
Via MarketMinute
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Stryker (SYK) Q4 2025 Earnings Call Transcript ↗
Stryker (SYK) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates
Medical technology company Stryker (NYSE:SYK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.4% year on year to $7.17 billion. Its non-GAAP profit of $4.47 per... 
Via StockStory
News headline image
Stryker reports 2025 operating results and 2026 outlook
From Stryker Corporation
Via GlobeNewswire
News headline image
Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation
MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra... 
Via MarketMinute
News headline image
What To Expect From Stryker’s (SYK) Q4 Earnings
Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what to expect. 
Via StockStory
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)... 
Via MarketMinute
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Avoid
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... 
Via StockStory
Topics Stocks
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A
As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Healthcare Bellwether Braces for Impact: UnitedHealth Group’s High-Stakes Q4 Outlook Signals a Sector-Wide Reset
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary... 
Via MarketMinute
Topics Earnings Economy Stocks
News headline image
Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?
Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical... 
Via PredictStreet
Topics Artificial Intelligence Economy Product Recall
News headline image
1 Oversold Stock Primed to Rebound and 2 That Underwhelm
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
News headline image
Stryker (SYK) Stock Trades Up, Here Is Why
Shares of medical technology company Stryker (NYSE:SYK) jumped 4.1% in the afternoon session after analyst firm Raymond James upgraded the stock to "Outperform" from "Market Perform" and set a $418... 
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
Why Stryker Stock Popped Today ↗
Does a 10% growth rate justify a 46x earnings stock price? 
Via The Motley Fool
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Stryker to announce financial results for its fourth quarter and full year 2025
From Stryker Corporation
Via GlobeNewswire
News headline image
2 Large-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
News headline image
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare... 
Via PredictStreet
Topics Economy Emissions Product Recall
News headline image
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗
This basket of 64 medical device stocks could raise its dividend for decades. 
Via The Motley Fool
Topics ETFs Government Supply Chain
News headline image
Dow Jones Soars to New Highs Amidst Economic Crosscurrents and AI Jitters
New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Profit Powerhouse: Strong Earnings Outlook Defies Market Slips, Signaling Continued Bull Run for US Stocks
Despite recent pockets of volatility and "slips" in the U.S. stock market during late 2025, a robust corporate profit outlook is emerging as a powerful counter-narrative, fueling investor optimism and... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.